# Intravital Microscopy in Human Solid Tumors

> **NCT03823144** · NA · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 85 (estimated)

## Conditions studied

- Solid Tumor, Adult
- Clinical Stage IV Gastric Cancer AJCC v8
- Malignant Solid Neoplasm
- Metastatic Colorectal Carcinoma
- Metastatic Gastric Carcinoma
- Metastatic Primary Malignant Brain Neoplasm
- Metastatic Sarcoma
- Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
- Resectable Colorectal Carcinoma
- Resectable Liver and Intrahepatic Bile Duct Carcinoma
- Resectable Pancreatic Carcinoma
- Resectable Sarcoma
- Stage IV Colorectal Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Malignant Brain Neoplasm
- Metastatic Breast Carcinoma
- Metastatic Liver Carcinoma
- Metastatic Pancreatic Carcinoma
- Resectable Brain Neoplasm
- Resectable Breast Carcinoma
- Resectable Gastric Carcinoma
- Stage IV Hepatocellular Carcinoma AJCC v8
- Stage IV Pancreatic Cancer AJCC v8

## Interventions

- **DEVICE:** Diagnostic Microscopy
- **DRUG:** Fluorescein Sodium Injection

## Key facts

- **NCT ID:** NCT03823144
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-02-28
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03823144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03823144, "Intravital Microscopy in Human Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03823144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*